Hostname: page-component-788cddb947-nxk7g Total loading time: 0 Render date: 2024-10-18T10:59:00.361Z Has data issue: false hasContentIssue false

Stenotrophomonas maltophilia Bloodstream Infection Outbreak in an Acute Care Hospital — Alameda County, California 2022–2023

Published online by Cambridge University Press:  16 September 2024

Sana Khan
Affiliation:
Centers for Disease Control and Prevention
Axel Vazquez Deida
Affiliation:
Centers for Disease Control and Prevention
Steven Langerman
Affiliation:
Centers for Disease Control and Prevention
Jennifer C. Hunter
Affiliation:
Centers for Disease Control and Prevention
Alison Halpin
Affiliation:
Centers for Disease Control and Prevention
Alyssa Kent
Affiliation:
Centers for Disease Control and Prevention
Paige Gable
Affiliation:
Centers for Disease Control and Prevention
Frances Knight
Affiliation:
Centers for Disease Control and Prevention
Amit Chitnis
Affiliation:
Centers for Disease Control and Prevention
Eileen Dunne
Affiliation:
Centers for Disease Control and Prevention
Kiran Perkins
Affiliation:
Centers for Disease Control and Prevention
Dustin Heaton
Affiliation:
Alameda County Public Health
Munira Shemsu
Affiliation:
Alameda County Public Health
Margarita Elsa Villarino
Affiliation:
Healthcare Associated Infections (HAI) Program, CDPH
Kavita Trivedi
Affiliation:
Alameda County Public Health Department
Jeffrey Silvers
Affiliation:
Sutter Health

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Stenotrophomonas maltophilia is an opportunistic pathogen found in healthcare settings. During April–September 2022, nine S. maltophilia bloodstream infections (BSIs) were identified among intensive care unit (ICU) patients at a hospital in Alameda County, California. Whole genome sequencing found isolates to be highly related. Despite implementation of infection prevention and control (IPC) interventions, four additional S. maltophilia BSIs were identified during June–September 2023. We investigated to identify risk factors for infection and stop transmission. Methods: We conducted a matched case-control study. A case was defined as S. maltophilia isolated from a blood culture from an ICU patient with a fever during April 2022–September 2023; control-patient subjects were patients admitted to the ICU during the same period with hospital stay greater than or equal to their matched case. Three control subjects were matched to each case. We extracted information on risk factors for infection from medical charts and observed IPC practices in hospital locations of interest. We collected environmental samples from the ICU, radiology unit, and emergency department. Results: Among 13 cases and 39 control subjects, patients exposed to iodinated contrast Omnipaque-300 (odds ratio [OR]: 5.7; 95% CI: 1.2–28.0), injectable propofol (OR: 12.2; 95% CI: 1.5–101.4), or fentanyl (OR: 9.2; 95% CI: 1.8–Inf.) were more likely to have a S. maltophilia BSI, compared with control-subjects. IPC deficiencies included improper cleaning and storage of medical equipment, including the contrast injection system, and patient care supplies. The outbreak strain of S. maltophilia was not isolated from environmental samples. Conclusions: Although a point-source was not identified, S. maltophilia was likely transmitted through improper IPC practices involving injectable contrast or anesthesia. Recommendations on proper cleaning and disinfection of the contrast injection system and proper storage, preparation, and administration of medications were made to reduce risk for contamination.

Type
Outbreaks
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America